Mokyr, Margalit B.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Some characteristics of the in vivo antitumor immunity exhibited by mice cured of a large MOPC-315 tumor by a low dose of melphalan

Edward Barker, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1987

Language:

english

File:

PDF, 1.24 MB

english, 1987

2

Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor

Robert C. Bocian, Sheldon Dray, Shlomo Ben-Efraim, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1985

Language:

english

File:

PDF, 967 KB

english, 1985

3

Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy

Sheldon Dray, Margalit B. Mokyr

Journal:

Medical Oncology

Year:

1989

Language:

english

File:

PDF, 835 KB

english, 1989

4

Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers

Margalit B. Mokyr, Edward Barker

Journal:

Cancer Immunology, Immunotherapy

Year:

1986

Language:

english

File:

PDF, 1.02 MB

english, 1986

5

Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor

Qing-Wei Ye, Margalit B. Mokyr, Joseph M. Pyle, Sheldon Dray

Journal:

Cancer Immunology, Immunotherapy

Year:

1984

Language:

english

File:

PDF, 928 KB

english, 1984

6

Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon γ in the therapeutic outcome

Leonid Gorelik, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1995

Language:

english

File:

PDF, 1.51 MB

english, 1995

7

B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cells

Dorothy K. Sojka, Ross N. La Motte, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

2000

Language:

english

File:

PDF, 561 KB

english, 2000

8

Activation of suppressor T cells by tumour cells and specific antibody

GERSHON, RICHARD K., MOKYR, MARGALIT BIRNBAUM, MITCHELL, MALCOLM S.

Journal:

Year:

1974

File:

PDF, 362 KB

1974

9

Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

Robert C. Bocian, Shlomo Ben-Efraim, Sheldon Dray, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1984

Language:

english

File:

PDF, 927 KB

english, 1984

10

On the Mode of Action of BCG

MITCHELL, M. S., KIRKPATRICK, DAHLIA, MOKYR, MARGALIT BIRNBAUM, GERY, IGAL

Journal:

Nature New Biology

Year:

1973

File:

PDF, 375 KB

1973

11

Phorbol ester-induced enhancement in lytic activity of CD8+splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers

Larry M. Weiskirch, Barbara A. Baumgartel, Edward Barker, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1991

Language:

english

File:

PDF, 1.62 MB

english, 1991

12

Two tumor models of curative adoptive chemoimmunotherapy using tumor-infiltrated spleen cells with potent antitumor cytotoxicity stimulated by antigen-sharing tumors

Maribeth Laude, Katherine L. Russo, Margalit B. Mokyr, Sheldon Dray

Journal:

Cancer Immunology, Immunotherapy

Year:

1993

Language:

english

File:

PDF, 909 KB

english, 1993

13

Cure of mice bearing a late-stage, highly metastatic, drug-resistant tumor by adoptive chemoimmunotherapy

Maribeth Laude, Katherine L. Russo, Margalit B. Mokyr, Sheldon Dray

Journal:

Cancer Immunology, Immunotherapy

Year:

1993

Language:

english

File:

PDF, 1.01 MB

english, 1993

14

Melphalan-induced up-regulation of B7–1 surface expression on normal splenic B cells

Manjula Donepudi, Vladimir M. Jovasevic, Pradip Raychaudhuri, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

2003

Language:

english

File:

PDF, 462 KB

english, 2003

15

Specific and non-specific immunologic mechanisms of tumor growth facilitation

Hisakazu Yamagishi, Neal R. Pellis, Margalit B. Mokyr, Dr. Barry D. Kahan

Journal:

Year:

1980

Language:

english

File:

PDF, 464 KB

english, 1980

16

Anti-metastatic activity of hapten-modified autologous tumor cell vaccine in an animal tumor model

Dorothy K. Sojka, Diana Felnerova, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

2002

Language:

english

File:

PDF, 168 KB

english, 2002

17

Activation of lymphoid cells by BCG in vitro

Margalit Birnbaum Mokyr, Malcolm S. Mitchell

Journal:

Cellular Immunology

Year:

1975

Language:

english

File:

PDF, 667 KB

english, 1975

18

Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma

Joan M. Cook-Mills, Margalit B. Mokyr, Rhonna L. Cohen, Robert L. Perlman, Donald A. Chambers

Journal:

Cancer Immunology, Immunotherapy

Year:

1995

Language:

english

File:

PDF, 931 KB

english, 1995

19

Importance of signaling via the IFN-α/β receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor

Margalit B. Mokyr, Aaron T. Place, James E. Artwohl, VE Ted Valli

Journal:

Cancer Immunology, Immunotherapy

Year:

2006

Language:

english

File:

PDF, 701 KB

english, 2006

20

Enhanced expansion of the thymic CD8+cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers

Mary M. Bartik, Barbara A. Baumgartel-Scofield, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1991

Language:

english

File:

PDF, 1.62 MB

english, 1991

21

Opposite Effects of Different Strains or Batches of Same Strain of BCG on In Vitro Generation of Syngeneic and Allogeneic Antitumor Cytotoxicity23

Mokyr, Margalit B., Bennett, James A., Braun, Donald P., Hengst, James C. D., Mitchell, Malcolm S., Dray, Sheldon

Journal:

JNCI Journal of the National Cancer Institute

Year:

1980

Language:

english

File:

PDF, 695 KB

english, 1980

22

Some approaches to improve the therapeutic effectiveness of adoptive chemoimmunotherapy with spleen cells from melphalan-treated BALB/C mice bearing a large MOPC-315 tumor

Larry M. Weiskirch, Margalit B. Mokyr

Journal:

International Journal of Cancer

Year:

1992

Language:

english

File:

PDF, 1020 KB

english, 1992

23

Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

Margalit B. Mokyr, Michael Colvin, Sheldon Dray

Journal:

International Journal of Immunopharmacology

Year:

1985

Language:

english

File:

PDF, 953 KB

english, 1985

24

Low-dose melphalan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumor

Leonid Gorelik, Anna Prokhorova, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1994

Language:

english

File:

PDF, 1.07 MB

english, 1994

25

Transforming growth factor-β-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy

Larry M. Weiskirch, Yifat Bar-Dagan, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1994

Language:

english

File:

PDF, 1.15 MB

english, 1994

26

The development of in vitro and in vivo anti-tumor cytotoxicity in noncytotoxic, MOPC-315-tumor-bearer, spleen cells “educated” in vitro with MOPC-315 tumor cells

Margalit B. Mokyr, D. P. Braun, D. Usher, H. Reiter, S. Dray

Journal:

Cancer Immunology, Immunotherapy

Year:

1978

Language:

english

File:

PDF, 701 KB

english, 1978

27

Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth

Shlomo Ben-Efraim, Robert C. Bocian, Margalit B. Mokyr, Sheldon Dray

Journal:

Cancer Immunology, Immunotherapy

Year:

1983

Language:

english

File:

PDF, 874 KB

english, 1983

28

Interplay Between the Toxic Effects of Anticancer Drugs and Host Antitumor Immunity in Cancer Therapy

Mokyr, Margalit B., Dray, Sheldon

Journal:

Cancer Investigation

Year:

1987

Language:

english

File:

PDF, 846 KB

english, 1987

29

Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas

James A. Wise, Margalit B. Mokyr, Sheldon Dray

Journal:

Cancer Immunology, Immunotherapy

Year:

1988

Language:

english

File:

PDF, 770 KB

english, 1988

30

Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy

Mary M. Bartik, Mi-Chung Ahn, Barbara A. Baumgartel, Robert L. Hendricks, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1990

Language:

english

File:

PDF, 1.50 MB

english, 1990

31

Progression of the Immune Response to Solubilized Tumor Antigens

Pellis, Neal R., Mokyr, Margalit B., Babcock, John R., Kahan, Barry D.

Journal:

Immunological Investigations

Year:

1978

Language:

english

File:

PDF, 385 KB

english, 1978

32

Antitumor Immunity in Strain 2 Guinea Pigs Immunized With Potassium Chloride Extracts of L 2 C Tumor Cells 2

Braun, Donald P., Hengst, James C. D., Mokyr, Margalit B., Dray, Sheldon

Journal:

JNCI Journal of the National Cancer Institute

Year:

1978

Language:

english

File:

PDF, 563 KB

english, 1978

33

Characterization of the exogenous interleukin-2 requirements for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers

Michael Rubin, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1993

Language:

english

File:

PDF, 922 KB

english, 1993

34

Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the lyt 2 and the L3T4 antigens

Blaine Y. Takesue, Mary M. Bartik, Margalit B. Mokyr

Journal:

International Journal of Immunopharmacology

Year:

1987

Language:

english

File:

PDF, 1.04 MB

english, 1987

35

Can the Bad Guys Be Defeated?

Mokyr, Margalit B.

Journal:

Cancer Investigation

Year:

1988

Language:

english

File:

PDF, 372 KB

english, 1988

36

Signaling through CD40 enhances cytotoxic T lymphocyte generation by CD8+T cells from mice bearing large tumors

Manjula Donepudi, Dong D. Quach, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1999

Language:

english

File:

PDF, 639 KB

english, 1999

37

Potentiation of Antitumor CTL Response by GM-CSF Involves a B7-Dependent Mechanism

Margalit B Mokyr, Tatiana V Kalinichenko, Leonid Gorelik

Journal:

Cellular Immunology

Year:

1997

Language:

english

File:

PDF, 239 KB

english, 1997

38

Purification of tumor-specific antigens. An overview of the relevance to human colon carcinoma

Dr. Barry D. Kahan, Baldwin H. Tom, Margalit B. Mokyr, Lynne P. Rutzky, Neal R. Pellis

Journal:

Year:

1975

Language:

english

File:

PDF, 457 KB

english, 1975

39

Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor

Larry M. Weiskirch, Edward Barker, Margalit B. Mokyr

Journal:

Cancer Immunology, Immunotherapy

Year:

1990

Language:

english

File:

PDF, 1.46 MB

english, 1990

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски